Keyphrases
Prostate Cancer
73%
Confidence Interval
38%
Biochemical Recurrence
25%
Hazard Ratio
25%
Black Men
24%
Prostate Cancer Aggressiveness
23%
Racial Differences
21%
Radical Prostatectomy
20%
Metformin Use
20%
White People
18%
Obesity
17%
Definitive Treatment
17%
Rural-urban
16%
Marital Status
16%
Cancer Risk
16%
Cancer Mortality
16%
Surveillance Epidemiology
16%
White Americans
15%
Adjusted Odds Ratio
14%
Diabetes
14%
Black Americans
14%
Prostate Cancer Screening
13%
Lung Cancer
13%
Prostate Cancer Recurrence
13%
Colorectal Cancer
13%
Patient Survival
13%
Post-diagnostic Support
13%
Statin Use
13%
Ethnic Differences
13%
Advanced Prostate Cancer
13%
Breast Cancer
13%
Population-based Study
13%
Nationally Representative Study
13%
Electronic Medical Records
13%
5-year Survival
13%
Prostate-specific Antigen Testing
13%
Prostate Cancer Risk
12%
North Carolina
12%
Body Mass Index
11%
Breast Cancer Mortality
10%
Prostate Cancer Patients
10%
United States
9%
Prospective Cohort Study
9%
Black Women
9%
Inverse Association
9%
Aggressive Prostate Cancer
9%
Veterans Health Administration
9%
Racially Diverse
8%
Diverse Populations
8%
Weight Change
8%
Medicine and Dentistry
Prostate Cancer
100%
Breast Cancer
26%
Malignant Neoplasm
26%
Race Difference
20%
Cancer Mortality
16%
Neoplasm
16%
Odds Ratio
15%
Surveillance, Epidemiology, and End Results
15%
Hazard Ratio
14%
Diabetes
13%
Cohort Effect
13%
Marital Status
13%
Lung Cancer
13%
Colorectal Carcinoma
13%
Prostatectomy
10%
Logistic Regression Analysis
9%
Health Care
8%
Cancer Screening
8%
Clinician
8%
Prostate Specific Antigen
7%
Prevalence
7%
Medical Record
7%
Cancer Growth
7%
Cancer Therapy
7%
Veterans Health
7%
Disease Exacerbation
6%
Physical Activity
6%
Urban Population
6%
Apoplexy
6%
Prostatitis
6%
Survivorship in Cancer Care
6%
Oncology
6%
Otitis Media
6%
Metastatic Breast Cancer
6%
4 Iodo 2,5 Dimethoxyamphetamine
6%
Systematic Review
6%
Racial Disparity
6%
Antigen
6%
Screening
6%
Electronic Patient Record
6%
Meta-Analysis
6%
Prognostic Factor
6%
Pediatric Brain Tumor
6%
Glycon
6%
Local Therapy
6%
Financial Toxicity
6%
Adverse Effect
6%
Diseases
6%
Enuresis
6%
Health Care Cost
6%